As a leading Chinese provider and manufacturer of biomedical consumable solutions, Suzhou CellPro Biotechnology is dedicated to one-stop consumable solutions for biopharmaceutical R&D, pilot-scale production, drug delivery, and packaging materials. Its products are widely used in research universities, biopharmaceuticals, cell and gene therapy, clinical medicine, and other fields.
As a domestic pioneer in biomedical consumables, CellPro Biotechnology has anchored its "domestic substitution for imports" strategy since its founding in 2018, committed to building a moat of "uninterrupted R&D and non-stop production" for life sciences enterprises and research institutions across the country.

In the face of industry upheaval, Suzhou CellPro Biotechnology focuses more on how to use mature project experience to build a "stability ecosystem" for biomedical consumables.From a stable pricing system, advanced R&D and innovation capabilities, and a complete quality certification system to strong large-scale mass production capacity, Suzhou CellPro Biotechnology delivers not only domestic substitution solutions, but also a reliable partner certified by customers in life science innovation and application-related fields across the country.
Stable pricing system: Diversified supply chain layout, stable prices, and customers widely distributed in life science innovation and application-related fields
Complete quality certification system: All CellPro Biotechnology products undergo strict quality inspection, and the quality certification system has passed relevant certifications such as ISO 9001, ISO13485, ISO45001, and ISO 15378.
Strong large-scale mass production capacity: Two large-scale production bases, more than 20,000 m² of Class 100,000 cleanrooms, as well as dynamic Class 10,000 production workshops and dynamic Class 100 production workshops, and unmanned fully automated production lines

✦
•
✦

✦
•
✦

✦
•
✦

From the fluctuations of the China-US trade war to the uncertainty of the global economy, we have deeply felt the challenges facing the industry, and have become even more determined to "build an independent and reliable life consumables industry chain."
We have always adhered to "stability, sustainability, and trustworthiness" as the core principles of development, assisting many enterprises and customers in continuing operations amid an uncertain market environment and achieving "nationwide layout with stable support." Against the backdrop of current global economic changes and in the face of various complex and ever-changing situations, Suzhou CellPro Biotechnology is willing to become the trustworthy "solid backing" for more and more enterprises.
We have always believed that doing our own work well, steadily and continuously providing customers with support and solutions, and taking every step well are the foundation for building long-term trust and cooperation. Trust comes from responsibility. Suzhou CellPro Biotechnology will always move forward side by side with you, overcome difficulties together, and create brilliance together!

Suzhou CellPro Biotechnology Co., Ltd., founded in 2018, is a leading provider and manufacturer of biomedical consumable solutions in China.
The company is committed to one-stop consumable solutions for R&D, pilot-scale production, drug delivery, and packaging materials in the biopharmaceutical field. They are widely used in scientific research universities, biopharmaceuticals, cell and gene therapy, clinical medicine, and other fields.
CellPro currently has more than 300 employees, a plant area of 35,000 ㎡, and has obtained more than 80 patents. It has also been approved as a Suzhou Enterprise Engineering Technology Research Center and has been awarded honors including a major leading talent enterprise in Suzhou Industrial Park, a Jiangsu Province science and technology SME, a national high-tech enterprise, a Jiangsu Province "specialized, refined, distinctive and innovative" SME, a Jiangsu Province gazelle cultivation enterprise, a Jiangsu Province "potential unicorn" enterprise, and a China "potential unicorn" enterprise.






Back to list




